Preliminary Report - ID Mapping
Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision Next revision Both sides next revision | ||
|
covid:unpublished [2020/05/01 16:34] biogridadmin |
covid:unpublished [2020/06/02 13:55] biogridadmin |
||
|---|---|---|---|
| Line 18: | Line 18: | ||
| | **888800000011** | **[[https://doi.org/10.1101/2020.03.16.993386|10.1101/2020.03.16.993386]]** | Gao Y (2020) | **[[https://thebiogrid.org/221198/publication|Structure of RNA-dependent RNA polymerase from 2019-nCoV, a major antiviral drug target]]** | | | **888800000011** | **[[https://doi.org/10.1101/2020.03.16.993386|10.1101/2020.03.16.993386]]** | Gao Y (2020) | **[[https://thebiogrid.org/221198/publication|Structure of RNA-dependent RNA polymerase from 2019-nCoV, a major antiviral drug target]]** | | ||
| | **888800000012** | **[[https://doi.org/10.1101/2020.03.31.019216|10.1101/2020.03.31.019216]]** | Liang Q (2020) | **[[https://thebiogrid.org/221199/publication|Virus-host interactome and proteomic survey of PMBCs from COVID-19 patients reveal potential virulence factors influencing SARS-CoV-2 pathogenesis]]** | | | **888800000012** | **[[https://doi.org/10.1101/2020.03.31.019216|10.1101/2020.03.31.019216]]** | Liang Q (2020) | **[[https://thebiogrid.org/221199/publication|Virus-host interactome and proteomic survey of PMBCs from COVID-19 patients reveal potential virulence factors influencing SARS-CoV-2 pathogenesis]]** | | ||
| - | |||
| | **888800000013** | **[[https://doi.org/10.1101/2020.04.15.042085|10.1101/2020.04.15.042085]]** | Bestle D (2020) | **[[https://thebiogrid.org/221402/publication|TMPRSS2 and furin are both essential for proteolytic activation and spread of SARS-CoV-2 in human airway epithelial cells and provide promising drug targets]]** | | | **888800000013** | **[[https://doi.org/10.1101/2020.04.15.042085|10.1101/2020.04.15.042085]]** | Bestle D (2020) | **[[https://thebiogrid.org/221402/publication|TMPRSS2 and furin are both essential for proteolytic activation and spread of SARS-CoV-2 in human airway epithelial cells and provide promising drug targets]]** | | ||
| - | |||
| | **888800000014** | **[[https://doi.org/10.1101/2020.04.09.033233|10.1101/2020.04.09.033233]]** | Jin Z (2020) | **[[https://thebiogrid.org/221403/publication|Structural basis for the inhibition of COVID-19 virus main protease by carmofur, an antineoplastic drug]]** | | | **888800000014** | **[[https://doi.org/10.1101/2020.04.09.033233|10.1101/2020.04.09.033233]]** | Jin Z (2020) | **[[https://thebiogrid.org/221403/publication|Structural basis for the inhibition of COVID-19 virus main protease by carmofur, an antineoplastic drug]]** | | ||
| - | |||
| | **888800000015** | **[[https://doi.org/10.1101/2020.04.08.032763|10.1101/2020.04.08.032763]]** | Yin W (2020) | **[[https://thebiogrid.org/221404/publication|Structural Basis for the Inhibition of the RNA-Dependent RNA Polymerase from SARS-CoV-2 by Remdesivir]]** | | | **888800000015** | **[[https://doi.org/10.1101/2020.04.08.032763|10.1101/2020.04.08.032763]]** | Yin W (2020) | **[[https://thebiogrid.org/221404/publication|Structural Basis for the Inhibition of the RNA-Dependent RNA Polymerase from SARS-CoV-2 by Remdesivir]]** | | ||
| - | |||
| | **888800000016** | **[[https://doi.org/10.1101/2020.04.14.042010|10.1101/2020.04.14.042010]]** | Chi X (2020) | **[[https://thebiogrid.org/221405/publication|Humanized Single Domain Antibodies Neutralize SARS-CoV-2 by Targeting Spike Receptor Binding Domain]]** | | | **888800000016** | **[[https://doi.org/10.1101/2020.04.14.042010|10.1101/2020.04.14.042010]]** | Chi X (2020) | **[[https://thebiogrid.org/221405/publication|Humanized Single Domain Antibodies Neutralize SARS-CoV-2 by Targeting Spike Receptor Binding Domain]]** | | ||
| + | | **888800000017** | **[[https://doi.org/10.1101/2020.04.06.20055475|10.1101/2020.04.06.20055475]]** | Ye L (2020) | **[[https://thebiogrid.org/221565/publication|Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor]]** | | ||
| + | | **888800000018** | **[[https://doi.org/10.1101/2020.04.19.049643|10.1101/2020.04.19.049643]]** | Zeng X (2020) | **[[https://thebiogrid.org/221566/publication|Blocking antibodies against SARS-CoV-2 RBD isolated from a phage display antibody library using a competitive biopanning strategy]]** | | ||
| + | | **888800000019** | **[[https://doi.org/10.1101/2020.04.23.057265|10.1101/2020.04.23.057265]]** | Peng Q (2020) | **[[https://thebiogrid.org/221567/publication|Structural and biochemical characterization of nsp12-nsp7-nsp8 core polymerase complex from COVID-19 virus]]** | | ||
| + | | **888800000020** | **[[https://doi.org/10.1101/2020.04.22.046565|10.1101/2020.04.22.046565]]** | Liu Y (2020) | **[[https://thebiogrid.org/221568/publication|Functional and Genetic Analysis of Viral Receptor ACE2 Orthologs Reveals Broad Potential Host Range of SARS-CoV-2]]** | | ||
| + | | **888800000021** | **[[https://doi.org/10.1101/2020.04.21.053017|10.1101/2020.04.21.053017]]** | Walker A (2020) | **[[https://thebiogrid.org/221569/publication|Enisamium is a small molecule inhibitor of the influenza A virus and SARS-CoV-2 RNA polymerases]]** | | ||
| + | | **888800000022** | **[[https://doi.org/10.1101/2020.04.17.047498|10.1101/2020.04.17.047498]]** | Rosas Lemus M (2020) | **[[https://thebiogrid.org/221570/publication|The crystal structure of nsp10-nsp16 heterodimer from SARS CoV-2in complex with S-adenosylmethionine]]** | | ||
| + | | **888800000023** | **[[https://doi.org/10.1101/2020.04.19.048710|10.1101/2020.04.19.048710]]** | Zhao X (2020) | **[[https://thebiogrid.org/221571/publication|Broad and differential animal ACE2 receptor usage by SARS-CoV-2]]** | | ||
| + | | **888800000024** | **[[https://doi.org/10.1101/2020.04.26.061705|10.1101/2020.04.26.061705]]** | Viswanathan T (2020) | **[[https://thebiogrid.org/221642/publication|Structural Basis of RNA Cap Modification by SARS-CoV-2 Coronavirus]]** | | ||
| + | | **888800000025** | **[[https://doi.org/10.1101/2020.04.29.068890|10.1101/2020.04.29.068890]]** | Rut W (2020) | **[[https://thebiogrid.org/221777/publication|Activity profiling of SARS-CoV-2-PLpro protease provides structural framework for anti-COVID-19 drug design]]** | | ||
| + | | **888800000026** | **[[https://doi.org/10.1101/2020.04.27.063180|10.1101/2020.04.27.063180]]** | Hillen HS (2020) | **[[https://thebiogrid.org/221778/publication|Structure of replicating SARS-CoV-2 polymerase]]** | | ||
| + | | **888800000027** | **[[https://doi.org/10.1101/2020.04.29.068098|10.1101/2020.04.29.068098]]** | Sun Z (2020) | **[[https://thebiogrid.org/221779/publication|Mass spectrometry analysis of newly emerging coronavirus HCoV-19 spike S protein and human ACE2 reveals camouflaging glycans and unique post-translational modifications]]** | | ||
| + | | **888800000028** | **[[https://doi.org/10.1101/2020.05.03.073080|10.1101/2020.05.03.073080]]** | Vuong W (2020) | **[[https://thebiogrid.org/221830/publication|Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication]]** | | ||
| + | | **888800000029** | **[[https://doi.org/10.1101/2020.05.02.20086876|10.1101/2020.05.02.20086876]]** | Zhang D (2020) | **[[https://thebiogrid.org/221831/publication|Ultra-fast and onsite interrogation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in environmental specimens via surface enhanced Raman scattering (SERS)]]** | | ||
| + | | **888800000030** | **[[https://doi.org/10.1101/2020.05.05.079202|10.1101/2020.05.05.079202]]** | Huo J (2020) | **[[https://thebiogrid.org/221832/publication|Neutralization of SARS-CoV-2 by destruction of the prefusion Spike]]** | | ||
| + | | **888800000031** | **[[https://doi.org/10.1101/2020.05.06.079830|10.1101/2020.05.06.079830]]** | Zha L (2020) | **[[https://thebiogrid.org/221833/publication|Development of a COVID-19 vaccine based on the receptor binding domain displayed on virus-like particles]]** | | ||
| + | | **888800000032** | **[[https://doi.org/10.1101/2020.05.02.043554|10.1101/2020.05.02.043554]]** | Gunther S (2020) | **[[https://thebiogrid.org/221835/publication|Catalytic cleavage of HEAT and subsequent covalent binding of the tetralone moiety by the SARS-CoV-2 main protease]]** | | ||
| + | | **888800000033** | **[[https://doi.org/10.1101/2020.05.01.20077743|10.1101/2020.05.01.20077743]]** | Wu Y (2020) | **[[https://thebiogrid.org/221836/publication|A non-competing pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2]]** | | ||
| + | | **888800000034** | **[[https://doi.org/10.1101/2020.05.03.074914|10.1101/2020.05.03.074914]]** | Liu X (2020) | **[[https://thebiogrid.org/221959/publication|Neutralizing Antibodies Isolated by a site-directed Screening have Potent Protection on SARS-CoV-2 Infection]]** | | ||